167 related articles for article (PubMed ID: 24151433)
1. Interaction of RAS activation and lipid disorders accelerates the progression of glomerulosclerosis.
Ma KL; Ni J; Wang CX; Liu J; Zhang Y; Wu Y; Lv LL; Ruan XZ; Liu BC
Int J Med Sci; 2013; 10(12):1615-24. PubMed ID: 24151433
[TBL] [Abstract][Full Text] [Related]
2. Lipid disorder and intrahepatic renin-angiotensin system activation synergistically contribute to non-alcoholic fatty liver disease.
Wu Y; Ma KL; Zhang Y; Wen Y; Wang GH; Hu ZB; Liu L; Lu J; Chen PP; Ruan XZ; Liu BC
Liver Int; 2016 Oct; 36(10):1525-34. PubMed ID: 27028410
[TBL] [Abstract][Full Text] [Related]
3. Effect and mechanism of the Ang-(1-7) on human mesangial cells injury induced by low density lipoprotein.
Huang W; Tang L; Cai Y; Zheng Y; Zhang L
Biochem Biophys Res Commun; 2014 Jul; 450(2):1051-7. PubMed ID: 24978313
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of dysregulation of low-density lipoprotein receptor expression in HepG2 cells induced by inflammatory cytokines.
Chen YX; Ruan XZ; Huang AL; Li Q; Moorhead JF; Varghese Z
Chin Med J (Engl); 2007 Dec; 120(24):2185-90. PubMed ID: 18167199
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation end products (AGEs) increase human mesangial foam cell formation by increasing Golgi SCAP glycosylation in vitro.
Yuan Y; Zhao L; Chen Y; Moorhead JF; Varghese Z; Powis SH; Minogue S; Sun Z; Ruan XZ
Am J Physiol Renal Physiol; 2011 Jul; 301(1):F236-43. PubMed ID: 21511699
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy.
Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Lu J; Zhang XL; Liu BC
Acta Diabetol; 2015 Dec; 52(6):1045-56. PubMed ID: 25896009
[TBL] [Abstract][Full Text] [Related]
7. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation.
Ma KL; Liu J; Wang CX; Ni J; Zhang Y; Wu Y; Lv LL; Ruan XZ; Liu BC
Cardiovasc Res; 2013 Dec; 100(3):450-60. PubMed ID: 24068000
[TBL] [Abstract][Full Text] [Related]
8. SREBP-1 Mediates Angiotensin II-Induced TGF-β1 Upregulation and Glomerular Fibrosis.
Wang TN; Chen X; Li R; Gao B; Mohammed-Ali Z; Lu C; Yum V; Dickhout JG; Krepinsky JC
J Am Soc Nephrol; 2015 Aug; 26(8):1839-54. PubMed ID: 25398788
[TBL] [Abstract][Full Text] [Related]
9. High glucose induces activation of the local renin‑angiotensin system in glomerular endothelial cells.
Peng H; Xing YF; Ye ZC; Li CM; Luo PL; Li M; Lou TQ
Mol Med Rep; 2014 Feb; 9(2):450-6. PubMed ID: 24337709
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN).
Yuan Y; Sun H; Sun Z
Lipids Health Dis; 2017 Jun; 16(1):126. PubMed ID: 28659153
[TBL] [Abstract][Full Text] [Related]
11. Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes.
Wang Z; Jiang T; Li J; Proctor G; McManaman JL; Lucia S; Chua S; Levi M
Diabetes; 2005 Aug; 54(8):2328-35. PubMed ID: 16046298
[TBL] [Abstract][Full Text] [Related]
12. Difference in LDL receptor feedback regulation in macrophages and vascular smooth muscle cells: foam cell transformation under inflammatory stress.
Ye Q; Lei H; Fan Z; Zheng W; Zheng S
Inflammation; 2014 Apr; 37(2):555-65. PubMed ID: 24297394
[TBL] [Abstract][Full Text] [Related]
13. [The effects of failure of low density lipoprotein receptor expression induced by inflammation on radial artery foam cell formation in patients with end-stage renal disease].
Ma KL; Liu J; Gao M; Ni J; Zhang Y; Zhang XL; Liu H; Huang HQ; Chen L; Wang YL; Liu BC
Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):464-8. PubMed ID: 24059991
[TBL] [Abstract][Full Text] [Related]
14. Sirolimus modifies cholesterol homeostasis in hepatic cells: a potential molecular mechanism for sirolimus-associated dyslipidemia.
Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z
Transplantation; 2007 Oct; 84(8):1029-36. PubMed ID: 17989609
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy.
Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Liu BC
Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1140-8. PubMed ID: 25921580
[TBL] [Abstract][Full Text] [Related]
16. Enhanced SCAP glycosylation by inflammation induces macrophage foam cell formation.
Zhou C; Lei H; Chen Y; Liu Q; Li LC; Moorhead JF; Varghese Z; Ruan XZ
PLoS One; 2013; 8(10):e75650. PubMed ID: 24146768
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of the Low-Density Lipoprotein Receptor Pathway Is Involved in Lipid Disorder-Mediated Organ Injury.
Zhang Y; Ma KL; Ruan XZ; Liu BC
Int J Biol Sci; 2016; 12(5):569-79. PubMed ID: 27019638
[TBL] [Abstract][Full Text] [Related]
18. Blockade of the renin-angiotensin system ameliorates apelin production in 3T3-L1 adipocytes.
Hung WW; Hsieh TJ; Lin T; Chou PC; Hsiao PJ; Lin KD; Shin SJ
Cardiovasc Drugs Ther; 2011 Feb; 25(1):3-12. PubMed ID: 21161354
[TBL] [Abstract][Full Text] [Related]
19. The sterol-sensing endoplasmic reticulum (ER) membrane protein TRC8 hampers ER to Golgi transport of sterol regulatory element-binding protein-2 (SREBP-2)/SREBP cleavage-activated protein and reduces SREBP-2 cleavage.
Irisawa M; Inoue J; Ozawa N; Mori K; Sato R
J Biol Chem; 2009 Oct; 284(42):28995-9004. PubMed ID: 19706601
[TBL] [Abstract][Full Text] [Related]
20. Renoprotective effect of myricetin restrains dyslipidemia and renal mesangial cell proliferation by the suppression of sterol regulatory element binding proteins in an experimental model of diabetic nephropathy.
Kandasamy N; Ashokkumar N
Eur J Pharmacol; 2014 Nov; 743():53-62. PubMed ID: 25240712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
